18 October 2017
News and Views
Links and Services
fiogf49gjkf04The latest issue of the American Journal of Gastroenterology performs an in-depth analysis of patient-reported outcomes in patients with chronic hepatitis C treated with different anti-viral regimens.
Interferon- and ribavirin-containing regimens negatively impact patients’ experience. <
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors